Answers are grounded in this paper and cite their sources.
This Viewpoint uses a 2017 US Food and Drug Administration (FDA) safety communication about the vulnerability of some cardiac pacemakers to malware to discuss medical device data security and patient safety more generally, and regulatory steps the FDA has and can take to combat the risks.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: